Neuroblastoma 1

Common Name(s)

Neuroblastoma 1

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroblastoma 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroblastoma 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Neuroblastoma 1" returned 219 free, full-text research articles on human participants. First 3 results:

Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma.
 

Author(s): P Bettinsoli, G Ferrari-Toninelli, S A Bonini, C Prandelli, M Memo

Journal:

 

Neuroblastoma is the most common extracranial solid malignancy in childhood, responsible for 15% of all pediatric cancer deaths. It is an heterogeneous disease that does not always respond to classical therapy; so the identification of new and specific molecular targets to improve ...

Last Updated: 31 Dec 1969

Go To URL
Radiolabeling and initial biological evaluation of [F]KBM-1 for imaging RAR-α receptors in neuroblastoma.
 

Author(s): Kiran Kumar Solingapuram Sai, Bhaskar C Das, Anirudh Sattiraju, Frankis G Almaguel, Suzanne Craft, Akiva Mintz

Journal: Bioorg. Med. Chem. Lett.. 2017 03;27(6):1425-1427.

 

Retinoic acid receptor alpha (RAR-α) plays a significant role in a number of diseases, including neuroblastoma. Children diagnosed with high-risk neuroblastoma are treated13-cis-retinoic acid, which reduces risk of cancer recurrence. Neuroblastoma cell death is mediated via RAR-α, ...

Last Updated: 31 Dec 1969

Go To URL
The Netrin-4/ Neogenin-1 axis promotes neuroblastoma cell survival and migration.
 

Author(s): Andrea A Villanueva, Paulina Falcón, Natalie Espinoza, Luis Solano R, Luis A Milla, Esther Hernandez-SanMiguel, Vicente A Torres, Pilar Sanchez-Gomez, Verónica Palma

Journal: Oncotarget. 2017 Feb;8(6):9767-9782.

 

Neogenin-1 (NEO1) is a transmembrane receptor involved in axonal guidance, angiogenesis, neuronal cell migration and cell death, during both embryonic development and adult homeostasis. It has been described as a dependence receptor, because it promotes cell death in the absence of ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Neuroblastoma 1" returned 0 free, full-text review articles on human participants.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

A Cancer Research UK Trial of Anti-GD2 T-cells (1RG-CART)
 

Status: Recruiting

Condition Summary: Relapsed or Refractory Neuroblastoma

 

Last Updated: 17 Mar 2017

Go to URL

Last Updated: 7 Feb 2018

Go to URL
High Risk Neuroblastoma Study 1.7 of SIOP-Europe (SIOPEN)
 

Status: Recruiting

Condition Summary: Neuroblastoma

 

Last Updated: 26 Sep 2016

Go to URL